Drugs and chemicals
All chemicals and reagents used in the present study were of analytical grade. Methyl paraben, liquid paraffin, polyethene glycol (PEG), beeswax, borax, petroleum ether, citric acid and distilled water were utilised in the experimental work. All the chemicals were procured from the laboratory of Sardar Bhagwan Singh University, Balawala, Dehradun, India and were used without further purification. All reagents were stored under appropriate conditions as per standard laboratory protocols to ensure stability and reliability of results. All experimental work was carried out in the laboratory of Sardar Bhagwan Singh University, Balawala, Dehradun, India in the year between 2025-2026.
Collection and identification
The plant seeds of
Moringa oleifera were obtained from the campus of Sardar Bhagwan Singh University (SBSU), Dehradun, India and
Celastrus paniculatus were obtained from the Swami Ram Teerth, (SRT) campus Botanical Garden, Badshahtithaul Tehri Garwal, Uttarakhand, India. The authentication of the given seeds plants was done through Botanical Survey India, (BSI) Dehradun, Uttarakhand, India and ICFRE-Forest Research Institute Dehradun, Uttarakhand, India. Authentication number for
Moringa oleifera was BSI/NRC.Herb(Ident.)/2024-25/646 and Authentication number for
Celastrus paniculatus was 790/Dis./2026-27/Syst.Bot./Rev.Gen./4-5.
Animals
All Albino Wistar rats of around 170-200 gm, aged between 8-10 weeks, were used in the investigation of the analgesic property of the topical cream. Animals were obtained from the Committee for Control and Supervision of Experimental Animals (CCSEA) registration no. (273/PO/Re/S/2000/CCSEA, 24
th November, 2000) further coordinated by Institutional Animal Ethics Committee (IAEC), (CCSEA/IAEC/SBS/2025-01/04, 20
th December, 2024) animal house facility at SBSU Dehradun, Uttarakhand, India. The animals were kept in the rat cages in the animal house at room temperature and fed with standard amount of food and water, 6 hr before the experiment. 12 hr of light and dark cycle for 7 day was done in order to make them comfortable with the environment maintained with proper hygiene. The study was conducted as per the norms of CCSEA.
Preparation of the experimental plant
The seeds of the selected plants were collected, thoroughly cleaned and dried at an appropriate temperature of 40°C for 10 day to remove moisture content. The dried seeds 200 grams each were then finely powdered using a mechanical grinder. The powdered material was subjected to Soxhlet extraction using petroleum ether (300 ml; temperature maintained in between 60-80°C for every 04 cycles each hour for 10 hours duration for both the plant materials separately) as the solvent, which is effective in extracting lipophilic compounds such as fats and oils. Upon completion of the extraction process, the solvent was removed from the extract using a rotary evaporator (rotavapor) under reduced pressure. The obtained seed oil was subsequently used for the preparation of the topical formulation.
Yield: 68 grams (34%) (
Moringa oleifera) and 102 grams (51%) (
Celastrus paniculatus) (Fig 1).
Standardization of Moringa oleifera seed oil
The standardization of
Moringa oleifera seed oil (Ben oil) was conducted to ensure its purity and high oleic acid content. The organoleptic evaluation confirmed a pale yellow, odorless liquid with a characteristic bland taste. Physicochemical parameters were determined, including specific gravity (0.900-0.915), refractive index (1.465-1.470), acid value (£2.0 mg KOH/g), iodine value (65-72 g /100g) and saponification value (185-195 mg KOH/g) (
Anwar and Bhanger, 2003).
Standardization of Celastrus paniculatus seed oil
Celastrus paniculatus seed oil (Malkanguni oil) was standardized based on its unique sesquiterpene and alkaloidal markers. The oil appeared as a dark reddish-orange, viscous liquid with a pungent odor and an acrid taste. Physicochemical parameters were determined, including specific gravity (0.940-0.960), refractive index (1.475-1.490) and a significantly higher unsaponifiable matter (typically 3-5%) compared to edible oils, which contains the bioactive alkaloids celastrine and paniculatine
(Sahu et al., 2020).
These physicochemical parameters provide preliminary standardization information as shown in Table 1.
Preparation and composition of the combined herbal cream
The herbal cream was prepared using the fusion method, involving the separate preparation of aqueous and oil phases. The aqueous phase was composed of distilled water (10 mL), propylene glycol (1.5 g) as a humectant and methyl paraben (0.1 g) as a preservative, with borax (0.1 g) added as an emulsifying agent. This mixture was heated until all components were completely solubilized. Simultaneously, the oil phase, consisting of beeswax (1.3 g) and liquid paraffin (2 mL), was heated until a uniform molten state was achieved. The aqueous phase was then gradually incorporated into the oil phase under continuous agitation using a laboratory stirrer to form a stable cream base.
To prepare the active formulations, the extracted combined oil blend (
Moringa oleifera and
Celastrus paniculatus) was incorporated into the pre-formed base to achieve final concentrations of 1%, 2% and 3% (w/w) (Fig 2). The pH of each formulation was monitored and adjusted using suitable acidifying or alkalizing agents to maintain a physiologically compatible range for topical application. The resulting creams were stirred until a homogenous consistency was obtained and stored for further analgesic evaluation. Quantitative Composition (Per Batch) is shown in Table 2.
Animal grouping
Twenty five healthy adult Wistar albino rats of either sex, weighing around 170 and 200 g, were housed under standard laboratory conditions (12 hrs light/dark cycle, temperature 25±2°C and relative humidity 50-60%) fed with standard amount of food and water, 6 hr before the experiment. The animals were divided into five groups, each group comprising of five rats (20 males and 05 females),
(Sarwa et al., 2015; Kumar et al., 2009; Dwivedi et al., 2013).
Group 1: Control,
i.e. one without any treatment.
Group 2: Standard,
i.e. application of the Diclofenac 1.16% (100 mg).
Group 3: Test group,
i.e. application of the formulated 1% of the seed oil cream (100 mg).
Group 4: Test group,
i.e. application of the formulated 2% of the seed oil cream (100 mg).
Group 5: Test group,
i.e. application of the formulated 3% of the seed oil cream (100 mg).
Physicochemical characterization of the formulated cream
The combined oil phase was prepared using
Moringa oleiferaand
Celastrus paniculatus seed oils in a 1:1 ratio by weight and this ratio was maintained for the 1%, 2% and 3% formulations (Table 2) and was subjected to rigorous physicochemical evaluation to ensure quality, stability and safety for topical application. The concentration of the total oil blend as well as the corresponding quantity of each individual oil would correspond to:
⮚1% total oil blend = 0.5%
Moringa oleiferaoil + 0.5%
Celastrus paniculatus oil.
⮚2% total oil blend = 1.0%
Moringa oleiferaoil + 1.0%
Celastrus paniculatus oil.
⮚3% total oil blend = 1.5%
Moringa oleiferaoil + 1.5%
Celastrus paniculatus oil.
Organoleptic evaluation and texture
The formulations were visually inspected for appearance (color and consistency) and evaluated for texture by manual application. The parameters assessed included smoothness, oiliness and the absence of coarse particles, ensuring a professional pharmaceutical aesthetic and user compliance.
Spreadability
Spreadability was evaluated to assess the ease of application and uniform distribution of the cream formulation over the intended application area. The test was performed using the two-glass-slide method. A measured quantity of formulation was placed between two glass slides and a standardized weight of 20 g was applied to the upper slide. The time required for the slides to separate over a specified distance was recorded.
Spreadability was calculated using the relationship:

Where,
S= Spreadability (g·cm/s).
M= The weight applied to the upper slide (20 g).
L= The length/distance of slide movement (5 cm).
T= The time required for separation (s).
The formulation showed a spreadability value of 29.6 g·cm/s, with a mean separation time of 3.37 s. These observations indicate that the formulation could be readily distributed over the application area.
pH measurement
The pH of the formulation was determined using a calibrated digital pH meter. A suitable quantity of the formulation was dispersed in distilled water before measurement and the pH was recorded after stabilization of the instrument reading. The pH of the formulations was found to be in the range of 5.5-5.8.
The pH measurement was used as a basic physicochemical characterization parameter relevant to topical application. The observed values were considered appropriate for the intended topical application; however, pH alone does not establish the absence of skin irritation or dermatological safety.
Rancidity and stability analysis
The rancidity of the oil within the formulation was monitored to assess oxidative degradation when exposed to environmental factors such as light and air. This parameter serves as a critical indicator of the shelf life and chemical stability of the bioactive lipid constituents.
The short-term stability of the formulation was evaluated by monitoring its observable physical characteristics under the specified experimental conditions. The formulation was examined for changes in appearance, colour, odour, consistency, phase separation and visible signs of deterioration during the observation period.
The stability assessment was therefore considered a short-term physical stability assessment. Because no validated chemical assay of the active constituents or degradation products was performed, the results do not establish long-term chemical stability, oxidative stability, or shelf life of the formulation.
Washability and absorbability
Washability was assessed qualitatively by applying a measured quantity of the cream formulation to the skin and subsequently evaluating the ease with which the formulation could be removed using water. The observation was recorded according to the ease of removal and the amount of visible residue remaining after washing.
Absorbability was assessed as a qualitative formulation property based on the apparent disappearance of the applied cream from the skin surface following topical application. This assessment was intended to characterize the handling and application characteristics of the formulation and was not used as a measure of dermal penetration or bioavailability.
The apparent absorption of the formulation into the skin cannot be equated with penetration of its constituents across the stratum corneum. Since no franz diffusion-cell study,
ex vivo skin permeation experiment, skin-deposition analysis, or pharmacokinetic assessment was performed, the present study does not establish dermal penetration, tissue distribution, or bioavailability of the active constituents.
Safety profile: Patch test
A preliminary patch test was conducted to assess the short-term local tolerability of the topical herbal formulation following dermal application. The formulation was applied topically to the designated skin site of the experimental animal in the quantity used for the original safety assessment. The treated site was observed for visible signs of local irritation, including erythema (redness), Edema and other apparent skin reactions during the observation period. The treated site was examined following application and again at 24 h after treatment. The presence or absence of visible erythema, Edema, or redness was recorded. The formulation produced no visibly detectable Edema, erythema, or redness after 24 h and the observed irritation score was 0 under the scoring procedure used in the original assessment (Fig 3).
Pharmacological evaluation
Eddy’s hot plate method (Thermal analgesia)
The centrally acting analgesic potential of the combined herbal formulations was evaluated using Eddy’s hot plate method. This model assesses the reaction time of rats to thermal stress, which serves as an indicator of pain threshold elevation.
Protocol
Five groups of five albino rats each were utilized for the study. The temperature of the caliberated, Eddy’s hot plate was maintained at a constant 55±0.2°C.
•
Group 1 (Negative control): Received no treatment to establish baseline latency.
•
Group 2 (Positive control): Treated with 100 mg Diclofenac (1.16% w/w) (Manufactured by Ozone Pharmaceutical LTD., Batch no GD371422) via topical application with 30 seconds on the right hind paw. The first hot-plate measurement was performed 30 min after topical administration.
•
Groups 3, 4 and 5 (Test groups): Treated with the 100 mg of formulated herbal cream at concentrations of 1%, 2% and 3% (w/w), respectively, applied topically same as group 2 animals, (Fig 4).
The reaction time, defined as the latency period for the animal to exhibit behaviours such as paw licking, jumping, or shaking, was recorded at intervals of 30, 60, 90 and 120 minutes post-application. To prevent tissue damage, a cut-off time of 15 seconds was maintained. The percentage inhibition of the pain response was calculated using the following formula:

The complete experiment was designed in accordance with previously reported methods
(Sarwa et al., 2015; Kumar et al., 2009; Dwivedi et al., 2013).
Carrageenan-induced hind paw edema (Anti-inflammatory activity)
The anti-inflammatory efficacy was assessed using the carrageenan-induced paw edema model, which represents the acute phase of inflammation.
Protocol
Five groups of five animals each were utilized for the study. Acute inflammation was induced via a sub-plantar injection (Levocarnitine by Akums Drugs and Pharmaceuticals Ltd. Batch no CAAD0006) of 0.1 mL of 1% sterile lambda carrageenan in saline into the right hind paw of each rat.
•
Pre-treatment: Sixty minutes prior to the carrageenan challenge, the test groups (Groups 3-5) received 100 mg of the prepared herbal formulations (1%, 2% and 3%).
•
Reference standard: Group 2 was treated with 100 mg of Diclofenac (1.16% w/w) cream as the standard reference drug.
•
Control: Group 1 received the cream base without active oils.
The degree of inflammation was quantified by measuring the paw volume using a digital plethysmometer (Ugo Basile) at 30, 60, 90 and 120 minutes following carrageenan injection. The paw edema volume (change in paw volume) was calculated as the difference between the volume of the carrageenan-injected right hind paw and that of the non-injected left hind paw at each time point. The anti-inflammatory activity was expressed as the percentage inhibition of paw edema in the treatment groups compared with the control group, calculated using the following equation:
Ethical approval and compliance
The experimental protocol was submitted to and approved by Institutional Animal Ethics Committee (IAEC), (CCSEA/IAEC/SBS/2025-01/04, 20th December, 2024). All procedures were conducted in strict accordance with the guidelines provided by the Institutional Animal Ethics Committee.
Animal housing and management
Wistar albino rats of either sex, weighing between 170-200 g, were utilized for the study. The animals were housed in polypropylene cages with sterile husk bedding in a controlled environment. The housing conditions were maintained at a temperature of 25±2°C and a relative humidity of 55±5%, under a regulated 12-hour light/dark cycle. The rats were fed with standard amount of food and water, 6 hr before the experiment. Prior to the commencement of the experiments, the animals were acclimatized to the laboratory conditions for a period of seven days to eliminate stress-induced physiological variations.
Dose justification
The combined herbal formulations were prepared at concentrations of 1%, 2% and 3% (w/w) to evaluate the pharmacological activity of different concentrations of the formulation. These concentrations were incorporated into the cream base to facilitate topical application and uniform distribution of the combined Moringa oleifera and Celastrus paniculatus seed oils. The selected concentration range was subsequently evaluated for analgesic and anti-inflammatory activity under the experimental conditions of the present study.